Salvatore Nesci
Ozzano Monferrato, 40064, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Redox-Dependent Modulation of Cardiac Mitochondrial F1FO-ATPase and Respiratory Function by N-Acetylcysteine and Sodium Ascorbate.
Journal: Biology
Published: July 20, 2026
The Dopaminergic Energy Crisis of Adolescent Depression: Mitochondrial Bioenergetics Control of Nucleus Accumbens Signaling.
Journal: Neuroscience bulletin
Published: April 10, 2026
A Biphasic Mitochondrial Damage-Management System: The Mitochondrial Derived Vescicles as Yin and Yang.
Journal: Journal of biochemical and molecular toxicology
Published: April 06, 2026
Beyond Bioenergetics: Moonlighting Functions of F1FO-ATPase From ATP Synthesis to an ATP-Wasting Death Switch.
Journal: Medicinal research reviews
Published: February 27, 2026
Mitochondrial Dysfunction in the Inflammatory Process of Neurodegenerative Diseases.
Journal: Biomedicines
Published: February 11, 2026
Mitochondrial permeability transition pore desensitization by a novel dispiranic derivative prevents cardiac reperfusion injury.
Journal: Redox biology
Published: February 05, 2026
Mitochondrial dysfunction in cerebrovascular diseases.
Journal: Trends in molecular medicine
Published: January 06, 2026
Mitochondrial signalling pathways in inflammation and health: mechanistic insights of mitochondrial impairment on cellular homeostasis in driving pathogenesis.
Journal: Journal of translational medicine
Published: November 19, 2025
Dextromethorphan Is a Novel Pharmacological Inhibitor of F1FO-ATPase That Targets the Membrane-Embedded Domain Impairing ATP Synthesis and Hydrolysis.
Journal: BioFactors (Oxford, England)
Published: November 18, 2025
Substitution of Mg2+ cofactor with Ca2+ disrupts positive cooperativity in F1FO-ATP(hydrol)ase catalysis.
Journal: Biochimica et biophysica acta. Bioenergetics
Published: November 03, 2025
Last Updated: 09/26/2026